Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide 3.0 mg for weight management in type 2 diabetes
NCT01272232Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2011
- Primary completion
- Jan 2013
- Modality
- Peptides
- Countries
- 13
01
Overview
A Phase 3 trial of liraglutide in obesity, Overweight, sponsored by Novo Nordisk. Started Jun 2011; status: completed.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT01272232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01272232.